Related Experiment Videos
Assessment of Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates to Ceftaroline and Other
Rishabh Gupta1, Saumya Agarwal1, Haniya Jafar1
1Department of Microbiology, Rohilkhand Medical College and Hospital, Bareilly, IND.
Abstract:
Introduction Methicillin-resistant Staphylococcus aureus (MRSA) remains a major cause of healthcare-associated infections and is associated with limited treatment options owing to its widespread antimicrobial resistance. This study aimed to evaluate the in vitro susceptibility of clinical MRSA isolates to ceftaroline and determine susceptibility patterns across demographic and clinical variables. Methods This cross-sectional observational study included 250 non-duplicate clinical MRSA isolates obtained from various clinical specimens. Antimicrobial susceptibility testing was performed in accordance with the guidelines of the Clinical and Laboratory Standards Institute (CLSI) guidelines. Demographic and microbiological data were analyzed using descriptive statistics, Pearson's chi-square test or Fisher's exact test, and Cramer's V effect-size measures. Pairwise comparisons between ceftaroline and each comparator antibiotic were conducted using McNemar's test. Results Among the 250 MRSA isolates, 158 (63.2%) were recovered from male patients and 92 (36.8%) from female patients. Overall, 212 (84.8%) isolates were susceptible to ceftaroline, 36 (14.4%) demonstrated intermediate susceptibility, and two (0.8%) were resistant. Ceftaroline susceptibility remained consistent across sexes (p=0.847), ages (p=0.312), hospital departments (p=0.862), and specimen types (p=0.931). Vancomycin showed 100% susceptibility, whereas linezolid showed 98.8% susceptibility. Complete resistance to several β-lactam antibiotics was observed. Conclusion Ceftaroline demonstrated substantial in vitro activity against clinical MRSA isolates, and remained effective across diverse demographic and clinical subgroups. These findings support its potential role as an additional therapeutic option for MRSA infections and highlight the importance of continued antimicrobial surveillance and susceptibility-guided therapy to monitor the emerging resistance patterns.
Insights
Ceftaroline shows high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA) isolates. Susceptibility remained consistent across patient demographics and specimen types, supporting its use for MRSA infections.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Pharmacy
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of healthcare-associated infections.
- Limited treatment options exist due to widespread antimicrobial resistance.
- Understanding ceftaroline's efficacy against MRSA is crucial for treatment strategies.
Purpose of the Study:
- To evaluate the in vitro susceptibility of clinical MRSA isolates to ceftaroline.
- To determine ceftaroline susceptibility patterns across demographic and clinical variables.
- To compare ceftaroline activity with other antibiotics.
Main Methods:
- Cross-sectional observational study of 250 clinical MRSA isolates.
- Antimicrobial susceptibility testing following CLSI guidelines.
- Statistical analysis of demographic, clinical, and microbiological data.
Main Results:
- 84.8% of MRSA isolates were susceptible to ceftaroline; 14.4% showed intermediate susceptibility.
- Ceftaroline susceptibility was consistent across sex, age, hospital department, and specimen type.
- Vancomycin and linezolid showed high susceptibility (100% and 98.8%, respectively).
Conclusions:
- Ceftaroline exhibits substantial in vitro activity against clinical MRSA isolates.
- Its effectiveness is consistent across various patient and clinical subgroups.
- Findings support ceftaroline as a potential therapeutic option for MRSA infections, emphasizing surveillance.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antimicrobial Effectiveness
Staphylococcal Skin Infections